-
Exome sequencing from cfDNA blood samples. 159 samples at 2x101bp Illumina reads in Fastq format.
Study
EGAS00001006656
-
Integrative analysis of exome-seq, RNA-seq, ATAC-seq (bulk and single-cell), and Hi-C data generated from 3-D spatially mapped samples acquired during surgical resection from 10 patients diagnosed with IDH-WT glioblastoma
Study
EGAS00001006785
-
RNASeq Neoantigen Immunogenicity Landscape
Study
EGAS00001007509
-
Multi-Layered Molecular Profiling Informs the Diagnosis and Targeted Therapy of Desmoplastic Small Round Cell Tumor
Study
EGAS00001007934
-
Transcriptome and Epigenome of TIL Infusion for Cancer Immunotherapy
Study
phs002436
-
Dana-Farber Cancer Institute (DFCI) Wu Lab/Avicenne CLL RNA-Seq Study
Study
phs002335
-
CRISPR-screening identifies mechanisms of resistance to KRASG12C and SHP2 inhibitor combinations in non-small cell lung cancer
Study
JGAS000643
-
Clinical Outcomes of 344 Diffuse Large B-Cell Lymphoma patients
Study
EGAS50000001054
-
Fecal microbiome subtype affects the clinical and genomic aberrations of colorectal cancer
Study
JGAS000696
-
Atezolizumab Plus Personalized Neoantigen Vaccination in Patients with Urothelial Cancer: a Phase 1 Trial
Study
phs003922
-
A Genome-Wide Association Study in Breast Cancer Patients from the Prospectively Randomized SUCCESS Trial
Study
phs000547
-
Therapy-Induced APOBEC3A Drives Evolution of Resistance to Targeted Therapies in Non-Small Cell Lung Cancer
Study
phs003256
-
Spatiotemporal single-cell analysis reveals a time-dependent immunological modulation by multi-fractionated radiotherapy in esophageal cancer
Study
JGAS000712
-
Recording physiological history of cells with chemical labeling.
Study
EGAS50000000056
-
Genomic and clinical characterization of a familial GIST kindred intolerant to imatinib
Study
EGAS50000000372
-
Sperm_PacBio_CCS_sequencing
Study
EGAS00001004958
-
High Density SNP Association Analysis of Melanoma: Case-Control and Outcomes Investigation
Study
phs000187
-
Women's Health Study Accelerometry Dataset
Study
phs001964
-
Combined Tumor and Immune Signals From Genomes or Transcriptomes Predict Outcomes of Checkpoint Inhibition in Melanoma
Study
phs002683
-
Population Architecture using Genomics and Epidemiology (PAGE): Multiethnic Cohort (MEC)
Study
phs000220
-
Metagenomic Analysis to Identify Novel Infectious Agents in Systemic Anaplastic Large Cell Lymphoma
Study
phs002064
-
Identifying novel DNA damage response genes in radiosensitive individuals
Study
phs001911
-
Regulatory Changes in Glioblastoma Brain Tumors and Xenografts Wave 1
Study
phs001646
-
A Scalable, GMP-Compatible, Autologous Organotypic Cell Therapy for Dystrophic Epidermolysis Bullosa
Study
phs003271
-
ctDNA to predict risk of progression and death after trifluridin/tipiracil therapy
Study
EGAS00001006883